Cochlear (ASX:COH) reported Friday that its six-month earnings per diluted share rose to AU$3.125 from AU$2.913 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting EPS of AU$3.17.
Underlying earnings were AU$3.139 per basic share, compared with AU$2.925 a year earlier.
Total revenue for the half year ended Dec. 31, 2024, was AU$1.17 billion, compared with AU$1.1 billion a year earlier. Analysts surveyed by Visible Alpha expected total revenue of AU$1.2 billion.
Sales revenue was AU$1.17 billion, up from AU$1.11 billion in the same period a year earlier.
The medical device firm expects 2025 underlying net profit at the lower end of the AU$410 million to AU$430 million guidance provided in August 2024. It also expects cochlear implant unit growth of around 10%.
The board declared an interim dividend of AU$2.15 per share, up from the AU$2 in the previously reported period, payable on April 14 to shareholders on record as of March 21.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.